MLchartDataset catalogue

T-DM1

Term · Oncology and biomedicine · MLC-T-ONC-008559

A drug used to treat certain patients with HER2-positive breast cancer that has already been treated with trastuzumab and a type of anticancer drug called a taxane. It is also being studied in the treatment of other types of cancer. T-DM1 contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some breast cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells. T-DM1 is a type of antibody-drug conjugate. Also called ado-trastuzumab emtansine and Kadcyla.

Table 1. Record
IdentifierMLC-T-ONC-008559
FieldOncology and biomedicine
Expansionsado-trastuzumab emtansine; Kadcyla
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008559",
  "term": "T-DM1",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat certain patients with HER2-positive breast cancer that has already been treated with trastuzumab and a type of anticancer drug called a taxane. It is also being studied in the treatment of other types of cancer. T-DM1 contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some breast cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells. T-DM1 is a type of antibody-drug conjugate. Also called ado-trastuzumab emtansine and Kadcyla.",
  "expansions": [
    "ado-trastuzumab emtansine",
    "Kadcyla"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/t-dm1/"
}

Record 16,048 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.